LAUR-201

N/A

Report date: 2025/07/25 16:27:20
NME

Base Information

Drug NameLAUR-201
Drug Alias NameLAUR-201
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionHuman immunodeficiency virus type 1 reverse transcriptase inhibitors
TargetsHuman immunodeficiency virus type 1 reverse transcriptase
Therapy Area/IndicationsAcquired Immunodeficiency Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLauren Sciences Llc
China Registration ClassN/A

Develop Information

Active CompaniesLauren Sciences Llc
Inactive CompaniesN/A
Active IndicationsAcquired Immunodeficiency Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A